Sinovac Biotech Ltd (SVA) stock
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.47+0.00 (0.00%)
Close on Nov 13, 2026Market cap $464.94MP/E –Yield 850.08%
Sinovac Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sinovac Biotech's enterprise value was -$3.55B on Nov 11, 2026, against -$7.45B a year earlier. Over the last 5 years it ranged from -$8.39B to -$169.36M, with a median of -$7.23B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.55B | – |
| 2025 | Dec 31, 2025 | -$7.45B | – |
| 2024 | Dec 31, 2024 | -$7.23B | – |
| 2023 | Dec 29, 2023 | -$6.32B | – |
| 2022 | Dec 30, 2022 | -$8.39B | – |
| 2021 | Dec 31, 2021 | -$169.36M | -134.4% |
| 2020 | Dec 31, 2020 | $491.93M | +51.4% |
| 2019 | Dec 31, 2019 | $325.01M | -0.2% |
| 2018 | Dec 31, 2018 | $325.71M | -24.1% |
| 2017 | Dec 29, 2017 | $428.99M | +39.8% |
| 2016 | Dec 30, 2016 | $306.92M | +5.1% |
| 2015 | Dec 31, 2015 | $291.98M | +35.6% |
| 2014 | Dec 31, 2014 | $215.29M | -17.5% |
| 2013 | Dec 31, 2013 | $260.98M | +214.1% |
| 2012 | Dec 31, 2012 | $83.08M | +120.4% |
| 2011 | Dec 30, 2011 | $37.69M | -68.4% |
| 2010 | Dec 31, 2010 | $119.29M | – |
See a number that looks wrong?